Browse EV MemProt Atlas
Frequency:
literature support frequency.
EVMP score:

annotation confidence score.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
UniProt IDProtein namesProtein classificationTransmembrane countRelated DiseasesMediation categoriesDownload
MRP1P33527Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter)Cancer-related genesDisease related genesEnzymesFDA approved drug targetsHuman disease related genesMetabolic proteinsPlasma proteinsPredicted membrane proteinsTransporters17GoutClinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediation10.50
MRP3O15438ATP-binding cassette sub-family C member 3 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Canalicular multispecific organic anion transporter 2) (Multi-specific organic anion transporter D) (MOAT-D) (Multidrug resistance-associated protein 3)Cancer-related genesEnzymesMetabolic proteinsPredicted intracellular proteinsPredicted membrane proteinsTransporters17Clinical-translation mediationFusion and delivery mediationMetabolism mediation10.50
MTM1Q13496Myotubularin (EC 3.1.3.95) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (Phosphatidylinositol-3-phosphate phosphatase)Disease related genesEnzymesHuman disease related genesMetabolic proteinsPlasma proteinsPotential drug targetsPredicted intracellular proteinsFusion and delivery mediationMetabolism mediationReceptor-signaling mediation10.50
MUC18P43121Cell surface glycoprotein MUC18 (Cell surface glycoprotein P1H12) (Melanoma cell adhesion molecule) (Melanoma-associated antigen A32) (Melanoma-associated antigen MUC18) (S-endo 1 endothelial-associated antigen) (CD antigen CD146)CD markersPlasma proteinsPredicted membrane proteins1Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationReceptor-signaling mediation10.50
MYO1CO00159Unconventional myosin-Ic (Myosin I beta) (MMI-beta) (MMIb)Predicted intracellular proteinsTransportersClinical-translation mediationFusion and delivery mediationImmune mediation10.50
MYO1EQ12965Unconventional myosin-Ie (Myosin-Ic) (Unconventional myosin 1E)Disease related genesHuman disease related genesPredicted intracellular proteinsFusion and delivery mediation10.50
MYO9AB2RTY4Unconventional myosin-IXa (Unconventional myosin-9a)Disease related genesHuman disease related genesPlasma proteinsPredicted intracellular proteins1Receptor-signaling mediation10.50
NAC1P32418Sodium/calcium exchanger 1 (Na(+)/Ca(2+)-exchange protein 1) (Solute carrier family 8 member 1)FDA approved drug targetsMetabolic proteinsPredicted intracellular proteinsPredicted membrane proteinsTransporters10Clinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediationReceptor-signaling mediation10.50
NCAM1P13591Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56)Cancer-related genesCD markersPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsPredicted secreted proteinsTransporters1Acute myeloid leukaemiaMultiple myelomaMyelodysplastic syndromeClinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation10.50
NCAM2O15394Neural cell adhesion molecule 2 (N-CAM-2) (NCAM-2)Plasma proteinsPredicted membrane proteins1Other mediation10.50
NCKX2Q9UI40Sodium/potassium/calcium exchanger 2 (Na(+)/K(+)/Ca(2+)-exchange protein 2) (Retinal cone Na-Ca+K exchanger) (Solute carrier family 24 member 2)11Fusion and delivery mediationMetabolism mediationReceptor-signaling mediation10.50
NCKX4Q8NFF2Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4)10Clinical-translation mediationFusion and delivery mediationMetabolism mediationReceptor-signaling mediation10.50
NEO1Q92859Neogenin (Immunoglobulin superfamily DCC subclass member 2)Cancer-related genesPlasma proteinsPredicted membrane proteins1Fusion and delivery mediationMetabolism mediation10.50
NEUMP17677Neuromodulin (Axonal membrane protein GAP-43) (Growth-associated protein 43) (Neural phosphoprotein B-50) (pp46)Plasma proteinsPredicted intracellular proteinsTransportersReceptor-signaling mediation10.50
NHRF1O14745Na(+)/H(+) exchange regulatory cofactor NHE-RF1 (NHERF-1) (Ezrin-radixin-moesin-binding phosphoprotein 50) (EBP50) (Regulatory cofactor of Na(+)/H(+) exchanger) (Sodium-hydrogen exchanger regulatory factor 1) (Solute carrier family 9 isoform A3 regulatory factor 1)Disease related genesHuman disease related genesPlasma proteinsPotential drug targetsPredicted intracellular proteinsTransportersFusion and delivery mediationReceptor-signaling mediation10.50
NHRF2Q15599Na(+)/H(+) exchange regulatory cofactor NHE-RF2 (NHERF-2) (NHE3 kinase A regulatory protein E3KARP) (SRY-interacting protein 1) (SIP-1) (Sodium-hydrogen exchanger regulatory factor 2) (Solute carrier family 9 isoform A3 regulatory factor 2) (Tyrosine kinase activator protein 1) (TKA-1)Predicted intracellular proteinsTransportersAdhesion and uptake mediationFusion and delivery mediation10.50
NK1RP25103Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1)FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins7Abnormal micturitionAcute diabete complicationAcute upper respiratory infectionAnxiety disorderAsthmaAtopic eczemaChronic obstructive pulmonary diseaseChronic painCoughDepressionEczemaFunctional bladder disorderHypertensionInfluenzaIntracranial injuryIrritable bowel syndromeMenopausal disorderMigraineMood disorderNausea/vomitingOesophagus motility disorderPainPrurigoPsoriasisSchizophreniaSkin tag/polypSolid tumour/cancerSubstance abuseClinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation10.50
NK2RP21452Substance-K receptor (SKR) (NK-2 receptor) (NK-2R) (Neurokinin A receptor) (Tachykinin receptor 2)7Abnormal micturitionAcute/chronic painAnxiety disorderAsthmaAtopic eczemaChronic obstructive pulmonary diseaseDepressionInfants/toddlers/children functional digestive disorderIrritable bowel syndromePainPostoperative ileusPsoriasisClinical-translation mediationFusion and delivery mediationReceptor-signaling mediation10.50
NKG2AP26715NKG2-A/NKG2-B type II integral membrane protein (CD159 antigen-like family member A) (NK cell receptor A) (NKG2-A/B-activating NK receptor) (CD antigen CD159a)1Fusion and delivery mediationImmune mediation10.50
NKG2CP26717NKG2-C type II integral membrane protein (CD159 antigen-like family member C) (NK cell receptor C) (NKG2-C-activating NK receptor) (CD antigen CD159c)1Fusion and delivery mediationImmune mediation10.50
NKPD1Q17RQ9NTPase KAP family P-loop domain-containing protein 1Predicted membrane proteins3Other mediation10.50
NMBRP28336Neuromedin-B receptor (NMB-R) (Epididymis tissue protein Li 185a) (Neuromedin-B-preferring bombesin receptor)7Immune mediationReceptor-signaling mediation10.50
NMUR2Q9GZQ4Neuromedin-U receptor 2 (NMU-R2) (G-protein coupled receptor FM-4) (G-protein coupled receptor TGR-1)G-protein coupled receptorsPredicted membrane proteins7Fusion and delivery mediationReceptor-signaling mediation10.50
NOS1P29475Nitric oxide synthase 1 (EC 1.14.13.39) (Constitutive NOS) (NC-NOS) (NOS type I) (Neuronal NOS) (N-NOS) (nNOS) (Nitric oxide synthase, brain) (bNOS) (Peptidyl-cysteine S-nitrosylase NOS1)Cancer-related genesEnzymesFDA approved drug targetsMetabolic proteinsPlasma proteinsPredicted intracellular proteinsTransportersHeadacheMigraineClinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation10.50
NPFF2Q9Y5X5Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor)7Receptor-signaling mediation10.50

876-900 of 2,176 proteins

Page